1. Home
  2. DSY vs FGEN Comparison

DSY vs FGEN Comparison

Compare DSY & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSY

Big Tree Cloud Holdings Limited Ordinary Shares

HOLD

Current Price

$0.35

Market Cap

39.9M

Sector

N/A

ML Signal

HOLD

Logo FibroGen Inc

FGEN

FibroGen Inc

HOLD

Current Price

$8.85

Market Cap

35.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSY
FGEN
Founded
2020
1993
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.9M
35.6M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
DSY
FGEN
Price
$0.35
$8.85
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$146.50
AVG Volume (30 Days)
124.0K
32.3K
Earning Date
01-01-0001
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
120.37
N/A
EPS
0.01
53.38
Revenue
$7,323,356.00
$8,298,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$28.97
$0.17
Revenue Growth
16.37
N/A
52 Week Low
$0.32
$4.85
52 Week High
$7.33
$21.94

Technical Indicators

Market Signals
Indicator
DSY
FGEN
Relative Strength Index (RSI) 19.08 49.39
Support Level $0.32 $7.99
Resistance Level $0.43 $8.55
Average True Range (ATR) 0.02 0.36
MACD 0.00 0.14
Stochastic Oscillator 21.87 94.20

Price Performance

Historical Comparison
DSY
FGEN

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, distribution, and sales of personal care products and other consumer goods. Operating under a consumer-to-manufacturer and merchant (C2M) model, the company integrates online and offline operations to enhance customer engagement, product innovation, and marketing efficiency. Specializing in feminine hygiene products such as sterilized feminine pads, menstrual pants, and related items, Big Tree Cloud leverages its platform to consolidate resources within China's personal care industry while building a consumer community that provides direct feedback and product insights.

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

Share on Social Networks: